What’s in a name?
Posted 31st August 2010 in Articles, Commercial | 1 comment
As the number of terms used in nomenclature of marketing activities increases, Chris Stevenson questions whether it’s time we standardised.
“That which we call a rose, by any other name would smell as sweet”. We may all agree with Juliet that her lover Romeo would…
Read the full articleLooking beyond pharma for portfolio optimisation
Posted 23rd August 2010 in Articles, Commercial | 1 comment
Trevor Brown outlines an exciting new project where pharma is looking to learn from other industries about how to improve portfolio management and optimisation.
Within an increasingly challenging environment, there is significant debate in the pharmaceutical industry directed at…
Read the full articleEngaging OLs ‘over time’ online for greater insight
Posted 19th August 2010 in Articles, Commercial | 5 comments
In a time-pressured, geographically-vast industry, Neil A. Jones discusses what should be considered to ensure effective online engagement with Opinion Leaders.
Despite all the promises of the web to engage opinion leaders and other key stakeholders online for…
Read the full articleWhat Are IDEAs Made Of: Brand names
Posted 13th August 2010 in Articles, Commercial | 1 comment
Mike Rea returns to question whether sufficient consideration is put into drug brand names. Are we playing it too safe?
This is not an industry that does what is easy instead of what is best.
This is not an industry that would ever…
Understanding “strategy”
Posted 5th August 2010 in Articles, Commercial | 4 comments
Welcoming back a previous author now in a new role, pharmaphorum finds Pete West perplexed to find so many people talking at cross-purposes about strategy.
Have you ever been half way through a conversation with someone and suddenly realised that the thing you thought you were discussing…
Read the full articleHow about considering profitable segmentation?
Posted 3rd August 2010 in Articles, Commercial | 2 comments
As competition continues to increase within the pharmaceutical world, Dr. Andree Bates advises on the benefits of customer segmentation and targeted marketing.
In today’s dynamic and competitive pharmaceutical environment, being able to effectively target your…
Read the full articleWhat Are IDEAs Made Of: Communications
Posted 30th July 2010 in Articles, Commercial | 2 comments
As means and methods of communications expand, Mike Rea asks whether we are focusing too much on the how and losing sight of the what.
It used to be that those involved in the process of communication understood which part of the process they were delivering against. Whether you use…
Read the full articleNew UK joint working initiative addresses heart disease
Posted 27th July 2010 in Articles, Commercial | 1 comment
Attending the launch of the UK’s ‘Partners in Health’ initiative, Paul Tunnah finds healthcare collaboration looking longer term beyond just drug intervention.
The old saying goes that “prevention is better than a cure” and, as words of wisdom go, it’s hard to disagree with in…
Read the full articleLessons from the past, optimism for the future
Posted 22nd July 2010 in Articles, Commercial, Interviews | 1 comment
In our latest interview Paul Tunnah talks to Nigel Brooksby, a well known figure in UK pharma, to hear his advice for the next generation of industry leaders.
One could be forgiven sometimes for thinking that there has never been a more challenging time to work in the pharma industry…
Read the full articleNew UK pharma code limits gifts but frees pharmacists
Posted 14th July 2010 in Articles, Commercial | 2 comments
The UK’s pharma authority has proposed a new code of practice and Steve Gray ponders what impact it might have on pharmaceutical industry promotion.
So, it’s now official – there will be a new code in 2011 and it goes live on 1st January. The proposals have been…
Read the full article